Société Synairgen plc CINNOBER BOAT
Actions
SNG
GB00B0381Z20
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Marsden
CEO | Chief Executive Officer | 57 | 01/11/03 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | 06/11 |
Marcin Mankowski
CTO | Chief Tech/Sci/R&D Officer | - | 03/10/23 |
Jody Brooks
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/04 |
Phillip Monk
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/10/06 |
Richard Hennings
PRN | Corporate Officer/Principal | - | 01/03/21 |
Helen Gearing
PRN | Corporate Officer/Principal | - | 01/12/21 |
Gareth Walters
LAW | General Counsel | - | 13/10/21 |
Richard Francis
PRN | Corporate Officer/Principal | - | 01/09/21 |
Simon Holden
SEC | Corporate Secretary | 48 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Simon Shaw
CHM | Chairman | 59 | 01/06/03 |
Stephen Holgate
FOU | Founder | 77 | 01/06/03 |
Richard Marsden
CEO | Chief Executive Officer | 57 | 01/11/03 |
David Campbell
BRD | Director/Board Member | 80 | 11/04/06 |
Felicity Gabbay
BRD | Director/Board Member | 72 | 29/09/22 |
Phillip Monk
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/10/06 |
Amanda Radford
BRD | Director/Board Member | 53 | 01/12/22 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | 06/11 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 201 374 975 | 195 153 037 ( 96,91 %) | 0 | 96,91 % |
Coordonnées société
Synairgen Plc
Mailpoint 810 Southampton General Hospital
SO16 6YD, Southampton
+44 23 8051 2800
http://www.synairgen.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+22,81% | 46,81 Md | |
+46,51% | 41,29 Md | |
-1,88% | 41,37 Md | |
-6,20% | 28,87 Md | |
+11,33% | 26,06 Md | |
-21,00% | 19,13 Md | |
-1,43% | 11,96 Md | |
+30,73% | 12,39 Md | |
-0,48% | 12,08 Md |